Recent Advances in Mechanisms and Treatments of Airway Remodeling in Asthma: A Message from the Bench Side to the Clinic

키워드

참고문헌 (129)

1. Broide DH, "Immunologic and inflammatory mechanisms that drive asthma progression to remodeling", J Allergy Clin Immunol, 121, pp.560~570 (2008)
2. Mauad T, "Asthma therapy and airway remod- eling", J Allergy Clin Immunol, 120, pp.997~1009 (2007)
3. Pascual RM, "Airway remodeling contributes to the progressive loss of lung function in asthma: an overview", J Allergy Clin Immunol, 116, pp.477~486 (2005)
4. Cho JY, "Inhibition of airway remodeling in IL-5-deficient mice", J Clin Invest, 113, pp.551~560 (2004)
5. Humbles AA, "A critical role for eosinophils in allergic airways remodeling", Science, 305, pp.1776~1779 (2004)
6. Fulkerson PC, "A central regulatory role for eosinophils and the eotaxin", CCR3 axis in chronic experimental allergic airway inflammation, 2006, pp.103, 16418~16423
7. Doherty TA, "The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling", Nat Med, 17, pp.596~603 (2011)
8. Cho JY, "Chronic OVA allergen challenged TNF p55", p75 receptor deficient mice have reduced airway remodeling, 2011, pp.11, 1038~1044
9. Yum HY, "Allergen-induced coexpression of bFGF and TGF-β1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-β1 expression in vitro", Int Arch Allergy Immunol, 155, pp.12~22 (2011)
10. Holgate ST, "Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma", J Allergy Clin Immunol, 105(2), pp.193~204 (2000)
11. Holgate ST, "A new look at the pathogenesis of asthma", Clin Sci (Lond), 118, pp.439~450 (2009)
12. Wang YH, "hymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses", Clin Exp Allergy, 39, pp.798~806 (2009)
13. Jacquet A, "Interactions of airway epithelium with protease allergens in the allergic response", Clin Exp Allergy, 41, pp.305~311 (2011)
14. Rothenberg ME, "Eosinophilia", N Engl J Med, 338, pp.1592~1600 (1998)
15. Lopez AF, "Recombinant human interleukin 5 is a selective activator of human eosinophil function", J Exp Med, 167, pp.219~224 (1988)
16. Flood-Page P, "Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics", J Clin Invest, 112, pp.1029~1036 (2003)
17. Haldar P, "Mepolizumab and exacerbations of refractory eosinophilic asthma", N Engl J Med, 360, pp.973~984 (2009)
18. Wegmann M, "Effects of a low-molecularweight CCR-3 antagonist on chronic experimental asthma", Am J Respir Cell Mol Biol, 36, pp.61~67 (2007)
19. Komai M, "A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial", peribronchial fibrosis induced by repeated antigen challenge in mice, 2010, pp.112, 203~213
20. Tateno H, "Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6’-sulfo-sialyl Lewis X as a preferred glycan ligand", Glycobiology, 15, pp.1125~1135 (2005)
21. Bochner BS, "Glycan array screening reveals a candidate ligand for Siglec-8", J Biol Chem, 280, pp.4307~4312 (2005)
22. Song DJ, "Anti-Siglec-F Antibody Reduces Allergen-Induced Eosinophilic Inflammation and Airway Remodeling", JOURNAL OF IMMUNOLOGY, 183(8), pp.5333~5341 (2009), AMER ASSOC IMMUNOLOGISTS
23. Cho JY, "Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13", RESPIRATORY RESEARCH, 11 (2010), BIOMED CENTRAL LTD
24. Luzina IG, "ccurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients", Arthritis Rheum, 48, pp.2262~2274 (2003)
25. Halwani R, "Role of transforming growth factor-β in airway remodeling in asthma", Am J Respir Cell Mol Biol, 44, pp.127~133 (2011)
26. Yanai M, "Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure", J Appl Physiol, 72, pp.1016~1023 (1992)
27. McMillan SJ, "Manipulation of allergeninduced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway", J Immunol, 174, pp.5774~5780 (2005)
28. Wynn TA, "Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases", J Clin Invest, 117, pp.524~529 (2007)
29. Le AV, "nhibition of allergen-induced airway remodeling in Smad 3-deficient mice", J Immunol, 178, pp.7310~7316 (2007)
30. Gregory LG, "Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25", Am J Respir Crit Care Med, 182, pp.143~154 (2010)
31. Redington AE, "Transforming growth factor-beta 1 in asthma: measurement in bronchoalveolar lavage fluid", Am J Respir Crit Care Med, 156, pp.642~647 (1997)
32. Chakir J, "Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression", J Allergy Clin Immunol, 111, pp.1293~1298 (2003)
33. Girodet PO, "Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention", Pharmacol Ther, 130, pp.325~337 (2011)
34. Bosse Y, "FGF2 in asthmatic airwaysmooth- muscle-cell hyperplasia", Trends Mol Med, 14, pp.3~11 (2008)
35. Bosse Y, "Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation", Am J Respir Cell Mol Biol, 34, pp.746~753 (2006)
36. Strutz F, "TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)", Kidney Int, 59, pp.579~592 (2001)
37. Qu Z, "Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules: morphological evidence for bfgf release through degranulation", J Histochem Cytochem, 46, pp.1119~1128 (1998)
38. Powers CJ, "Fibroblast growth factors, their receptors and signaling", Endocr Relat Cancer, 7, pp.165~197 (2000)
39. Bosse Y, "Transforming growth factor-beta1 in asthmatic airway smooth muscle enlargement: is fibroblast growth factor-2 required", Clin Exp Allergy, 40, pp.710~724 (2010)
40. Cho SH, "Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells", J Immunol, 170, pp.4045~4052 (2003)
41. Jeon SG, "Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge", J ALLERG CLIN IMMUNOL, 119, pp.831~837 (2007), MOSBY-ELSEVIER
42. Kanazawa H, "Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways", Chest, 132, pp.1169~1174 (2007)
43. Redington AE, "Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge", J Allergy Clin Immunol, 107, pp.384~387 (2001)
44. Clauss M, "Functions of the VEGF receptor-1 (FLT-1) in the vasculature", Trends Cardiovasc Med, 8, pp.241~245 (1998)
45. Charan NB, "Bronchial vascular congestion and angiogenesis", Eur Respir J, 10, pp.1173~1180 (1997)
46. Antony AB, "Cockroach extract antigen increases bronchial airway epithelial permeability", J Allergy Clin Immunol, 110, pp.589~595 (2002)
47. Lee CG, "Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung", Nat Med, 10, pp.1095~1103 (2004)
48. 김윤근, "Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(29), pp.11021~11026, NATL ACAD SCIENCES
49. Asai K, "Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects", J Allergy Clin Immunol, 110, pp.571~575 (2002)
50. Abdel-Rahman AM, "A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack", Chest, 129, pp.266~271 (2006)
51. Bae YJ, "Vascular endothelial growth factor levels in induced sputum and emphysematous changes in smoking asthmatic patients", Ann Allergy Asthma Immunol, 103, pp.51~56 (2009)
52. Costa JJ, "Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha", J Clin Invest, 91, pp.2673~2684 (1993)
53. Reuter S, "Mast cell-derived tumour necrosis factor is essential for allergic airway disease", Eur Respir J, 31, pp.773~782 (2008)
54. Nakae S, "Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice", J Allergy Clin Immunol, 120, pp.48~55 (2007)
55. Berry MA, "Evidence of a role of tumor necrosis factor alpha in refractory asthma", N Engl J Med, 354, pp.697~708 (2006)
56. Vandenbroucke RE, "A therapeutic role for MMP inhibitors in lung diseases", Eur Respir J, 38, pp.1200~1214 (2011)
57. Lim DH, "Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice", Am J Physiol Lung Cell Mol Physiol, 291, pp.265~271 (2006)
58. Lee YC, "The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma", Clin Exp Allergy, 31, pp.1623~1630 (2001)
59. Van Eerdewegh P, "Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness", Nature, 418, pp.426~430 (2002)
60. Jie Z, "The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation", Respir Physiol Neurobiol, 168, pp.289~294 (2009)
61. Foley SC, "Increased expression of ADAM33 and ADAM8 with disease progression in asthma", J Allergy Clin Immunol, 119, pp.863~871 (2007)
62. Lloyd CM, "IL-33 family members and asthma - bridging innate and adaptive immune responses", Curr Opin Immunol, 22, pp.800~806 (2010)
63. Shan L, "Thymic stromal lymphopoietin receptor-mediated IL-6 and CC", CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1, J Immunol, pp.2010, 184[DOI]
64. Al-Shami A, "A role for TSLP in the development of inflammation in an asthma model", J Exp Med, 202, pp.829~839 (2005)
65. Zhang F, "A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells", Clin Exp Immunol, 164, pp.256~264 (2011)
66. Heijink IH, "House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium", Am J Respir Cell Mol Biol, 42, pp.69~79 (2010)
67. Heijink IH, "Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction", Eur Respir J, 36, pp.1016~1026 (2010)
68. Ying S, "Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity", J Immunol, 174, pp.8183~8190 (2005)
69. Ying S, "Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease", J Immunol, 181, pp.2790~2798 (2008)
70. Zhou B, "Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice", Nat Immunol, 6, pp.1047~1053 (2005)
71. Owyang AM, "Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract", J Exp Med, 203, pp.843~849 (2006)
72. Angkasekwinai P, "Interleukin 25 promotes the initiation of proallergic type 2 responses", J Exp Med, 204, pp.1509~1517 (2007)
73. Fort MM, "IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo", Immunity, 15, pp.985~995 (2001)
74. Hurst SD, "New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25", J Immunol, 169, pp.443~453 (2002)
75. Corrigan CJ, "T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma", Proc Natl Acad Sci U S A, 108, pp.1579~1584 (2011)
76. Schmitz J, "IL-33, an interleukin-1- like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines", Immunity, 23, pp.479~490 (2005)
77. Sanada S, "IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system", J Clin Invest, 117, pp.1538~1549 (2007)
78. Moussion C, "The IL-1-like cytokine IL- 33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’", PLoS One, 3, pp.3331~ (2008)
79. Wood IS, "IL-33, a recently identified interleukin- 1 gene family member, is expressed in human adipocytes", Biochem Biophys Res Commun, 384, pp.105~109 (2009)
80. Kurowska-Stolarska M, "IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation", J Immunol, 183, pp.6469~6477 (2009)
81. Kondo Y, "Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system", Int Immunol, 20, pp.791~800 (2008)
82. Zhiguang X, "Over-expression of IL- 33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice", Immunol Lett, 131, pp.159~165 (2010)
83. Liu X, "Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma", Biochem Biophys Res Commun, 386, pp.181~185 (2009)
84. Coyle AJ, "Crucial role of the interleukin 1 receptor family member T1", ST2 in T helper cell type 2-mediated lung mucosal immune responses, 1999, pp.190, 895~902
85. Rankin AL, "IL-33 induces IL-13- dependent cutaneous fibrosis", J Immunol, 184, pp.1526~1535 (2010)
86. Prefontaine D, "Increased IL-33 expression by epithelial cells in bronchial asthma", J Allergy Clin Immunol, 125, pp.752~754 (2010)
87. Smith DE, "IL-33: a tissue derived cytokine pathway involved in allergic inf lammation and asthma", Clin Exp Allergy, 40, pp.200~208 (2010)
88. Rasmussen F, "Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1", vital capacity ratio: a longitudinal population study from childhood to adulthood, 2002, pp.165, 1480~1488
89. Mitsunobu F, "The use of computed tomography to assess asthma severity", Curr Opin Allergy Clin Immunol, 5, pp.85~90 (2005)
90. Gupta S, "Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes", Thorax, 65, pp.775~781 (2010)
91. Aysola R, "Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium-3 MRI", J Magn Reson Imaging, 32, pp.1379~3187 (2010)
92. de Lange EE, "Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry", Chest, 130, pp.1055~1062 (2006)
93. Fain SB, "Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI", Acad Radiol, 15, pp.753~762 (2008)
94. Delimpoura V, "Increased levels of osteopontin in sputum supernatant in severe refractory asthma", Thorax, 65, pp.782~786 (2010)
95. Broekema M, "Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma", Am J Respir Crit Care Med, 183, pp.310~316 (2011)
96. Wang K, "Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma", Acta Pharmacol Sin, 32, pp.126~132 (2011)
97. Nami Shrestha Palikhe, "Biomarkers Predicting Isocyanate-Induced Asthma", Allergy, Asthma & Immunology Research, 3(1), pp.21~26 (2011), 대한천식알레르기학회
98. Soja J, "The use of endobronchial ultrasonography in assessment of bronchial wall remodeling in patients with asthma", Chest, 136, pp.797~804 (2009)
99. Holgate S, "The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation", J Allergy Clin Immunol, 115, pp.459~465 (2005)
100. Rabe KF, "Can anti-IgE therapy prevent airway remodeling in allergic asthma", Allergy, 66, pp.1142~1151 (2011)
101. van Rensen EL, "Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment", Allergy, 64, pp.72~80 (2009)
102. Holgate S, "Effects of omalizumab on markers of inflammation in patients with allergic asthma", Allergy, 64, pp.1728~1736 (2009)
103. Kang JY, "Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma", J Asthma, 47, pp.374~380 (2010)
104. Corren J, "Cytokine inhibition in severe asthma: current knowledge and future directions", Curr Opin Pulm Med, 17, pp.29~33 (2011)
105. Nair P, "Mepolizumab for prednisone-dependent asthma with sputum eosinophilia", N Engl J Med, 360, pp.985~993 (2009)
106. Gruenberg D, "Biologic therapies for asthma", Curr Opin Pulm Med, 16, pp.19~24 (2010)
107. Holgate ST, "Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial", Eur Respir J, 37, pp.1352~1359 (2011)
108. Erin EM, "The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma", Am J Respir Crit Care Med, 174, pp.753~762 (2006)
109. Wenzel SE, "A randomized, double- blind, placebo-controlled study of tumor necrosis factoralpha blockade in severe persistent asthma", Am J Respir Crit Care Med, 179, pp.549~558 (2009)
110. Borish LC, "Efficacy of soluble IL-4 receptor for the treatment of adults with asthma", J Allergy Clin Immunol, 107, pp.963~970 (2001)
111. Hart TK, "Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma", Clin Exp Immunol, 130, pp.93~100 (2002)
112. Wenzel S, "Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies", Lancet, 370, pp.1422~1431 (2007)
113. Corren J, "A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma", Am J Respir Crit Care Med, 181, pp.788~796 (2010)
114. Busse WW, "Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial", Am J Respir Crit Care Med, 178, pp.1002~1008 (2008)
115. Berlin AA, "Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergeninduced asthma", Lab Invest, 86, pp.557~565 (2006)
116. Humbert M, "Masitinib, a c-kit", PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics, 2009, pp.64, 1194~1201
117. Dube J, "Synergistic action of endothelin (ET)-1 on the activation of bronchial fibroblast isolated from normal and asthmatic subjects", Int J Exp Pathol, 81, pp.429~437 (2000)
118. Taille C, "ETB receptor polymorphism is associated with airway obstruction", BMC Pulm Med, 7, pp.5~ (2007)
119. Zhu G, "Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations", Genes Immun, 9, pp.23~29 (2008)
120. Trian T, "Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma", J Exp Med, 204, pp.3173~3181 (2007)
121. Menzies D, "Simvastatin does not exhibit therapeutic antiinf lammatory effects in asthma", J Allergy Clin Immunol, 119, pp.328~335 (2007)
122. Hothersall EJ, "Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma", Thorax, 63, pp.1070~1075 (2008)
123. Danek CJ, "Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs", J Appl Physiol, 97, pp.1946~1953 (2004)
124. Miller JD, "A prospective feasibility study of bronchial thermoplasty in the human airway", Chest, 127, pp.1999~2006 (2005)
125. Cox G, "Bronchial thermoplasty for asthma", Am J Respir Crit Care Med, 173, pp.965~969 (2006)
126. Cox G, "Asthma control during the year after bronchial thermoplasty", N Engl J Med, 356, pp.1327~1337 (2007)
127. Castro M, "Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial", Am J Respir Crit Care Med, 181, pp.116~124 (2010)
128. Castro M, "Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma", Ann Allergy Asthma Immunol, 107, pp.65~70 (2011)
129. Thomson NC, "Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial", BMC Pulm Med, 11, pp.8~ (2011)

관련 논문AI추천